Reply to Heitjan's commentary.
作者信息
Fay Michael P, Li Fan
机构信息
Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, MD, USA.
Department of Biostatistics, Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, CT, USA.
出版信息
Clin Trials. 2024 Oct;21(5):638-639. doi: 10.1177/17407745241243311. Epub 2024 Apr 28.
Abstract
摘要
相似文献
1
Reply to Heitjan's commentary.
Clin Trials. 2024 Oct;21(5):638-639. doi: 10.1177/17407745241243311. Epub 2024 Apr 28.
2
Rounding behavior in the reporting of headache frequency complicates headache chronification research.
Headache. 2013 Jun;53(6):908-19. doi: 10.1111/head.12126.
3
A reply to the commentary "Deepening temporal cues in reading manipulations for dyslexia: A commentary on Horowitz-Kraus et al.".
Cortex. 2024 May;174:256-259. doi: 10.1016/j.cortex.2024.03.007. Epub 2024 Mar 23.
4
In reply to the commentary to Commentary to "Remifentanil for labour pain relief".
Anaesthesiol Intensive Ther. 2016;48(1):59-60. doi: 10.5603/AIT.2016.0009.
5
Reply to Commentary to Skudlik et al. (2023): why a scoping review and why only Germany?
BMC Nurs. 2024 Jun 17;23(1):407. doi: 10.1186/s12912-024-02078-6.
6
Reply to Siyu Tan: Associations of cardiovascular health assessed by life's essential 8 with diabetic retinopathy and mortality in type 2 diabetes. The author's reply.
Prim Care Diabetes. 2023 Dec;17(6):669-670. doi: 10.1016/j.pcd.2023.09.005. Epub 2023 Oct 2.
7
Jealousy reconsidered: a reply to DeSteno (2010).
Evol Psychol. 2011 Mar 7;9(1):116-7. doi: 10.1177/147470491100900112.
8
Commentary. On the epidemiology of influenza: reply to Radonovich et al.
Virol J. 2009 Aug 11;6:121. doi: 10.1186/1743-422X-6-121.
9
Commentary on the results of the economic survey of veterinary practice in Atlantic Canada - A reply.
Can Vet J. 1994 Sep;35(9):535.
10
Reply to Commentary on "A Universal Craniometric Index for Establishing the Diagnosis of Basilar Invagination".
Neurospine. 2021 Sep;18(3):646-647. doi: 10.14245/ns.2142516.258. Epub 2021 Sep 30.
本文引用的文献
1
Causal interpretation of the hazard ratio in randomized clinical trials.
Clin Trials. 2024 Oct;21(5):623-635. doi: 10.1177/17407745241243308. Epub 2024 Apr 28.
2
Using principal stratification in analysis of clinical trials.
Stat Med. 2022 Aug 30;41(19):3837-3877. doi: 10.1002/sim.9439. Epub 2022 Jun 13.
3
Subtleties in the interpretation of hazard contrasts.
Lifetime Data Anal. 2020 Oct;26(4):833-855. doi: 10.1007/s10985-020-09501-5. Epub 2020 Jul 11.
4
Limitations of hazard ratios in clinical trials.
Eur Heart J. 2019 May 1;40(17):1378-1383. doi: 10.1093/eurheartj/ehy770.
5
Does Cox analysis of a randomized survival study yield a causal treatment effect?
Lifetime Data Anal. 2015 Oct;21(4):579-93. doi: 10.1007/s10985-015-9335-y. Epub 2015 Jun 24.
6
The hazards of hazard ratios.
Epidemiology. 2010 Jan;21(1):13-5. doi: 10.1097/EDE.0b013e3181c1ea43.
7
Principal stratification in causal inference.
Biometrics. 2002 Mar;58(1):21-9. doi: 10.1111/j.0006-341x.2002.00021.x.
Zotero 插件